The weekly litigation news digest is live. Subscribe now

Collagen Hydrolysate For Use In Prevention And/Or Treatment Of Post Intensive Care Syndrome (Pics) - EP4392050

The patent EP4392050 was granted to Rousselot on Feb 12, 2025. The application was filed on Aug 30, 2023 under application number EP23764306A. The patent is currently recorded with a legal status of "Granted And Under Opposition".

EP4392050

ROUSSELOT
Application Number
EP23764306A
Filing Date
Aug 30, 2023
Status
Granted And Under Opposition
Jan 10, 2025
Publication Date
Feb 12, 2025
External Links
Slate, Register, Google Patents

Patent Summary

Patent Family

Patent Family

Patent Oppositions

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentativeOpposition Status
FRESENIUS KABI DEUTSCHLANDNov 7, 2025FRESENIUS KABI DEUTSCHLANDADMISSIBLE

Patent Citations (2) New

Patent citations refer to prior patents cited during different phases such as opposition or international search.

Citation PhasePublication Number
INTERNATIONAL-SEARCH-REPORTWO2020245299
OPPOSITIONWO2020245299

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents